4-Oxoquinoline Synthesis Bypassing Dimer Formation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current production methods for anti-HIV agents like compound (10) face challenges such as low yield due to by-production of dimers, corrosion from hydrofluoric acid, and complex operations for removing impurities like zinc and palladium salts, making them unsuitable for industrial-scale production.

Innovation Solution

The use of compounds (6), (7-1), (7-2), and (8) as synthetic intermediates, which bypass the issues of dimer formation and acid corrosion, allowing for a more straightforward and efficient production process by incorporating a methoxy group and using stable intermediates that tolerate severe conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional production methods (using compounds with hydroxyl-protecting groups or direct fluorination) are used, then the anti-HIV agent can be produced, but the yield decreases due to by-production of dimers and corrosion from hydrofluoric acid occurs

Engineering Contradiction:
ImproveyieldVSAvoiddimer by-production and hydrofluoric acid corrosion
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent extracts and removes the problematic hydroxyl-protecting group steps from the synthesis pathway by using a methoxy group instead. This eliminates the need for protection-deprotection cycles that lead to dimer formation and avoids hydrofluoric acid corrosion, directly resolving the technical contradiction between maintaining productivity and eliminating harmful factors.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the chemical parameter of the substituent group from a hydroxyl-protecting group (requiring harsh deprotection conditions with hydrofluoric acid) to a methoxy group (stable under reaction conditions). This parameter change eliminates dimer by-production and prevents corrosion while maintaining the desired synthetic outcome.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If production methods involving zinc and palladium salts are used, then the anti-HIV agent can be produced, but complex operations are required for removing impurities

Engineering Contradiction:
Improveproduction efficiencyVSAvoidcomplexity of impurity removal operations
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent removes the need for zinc and palladium salt-based catalytic systems by using alternative chemistry that does not require these metals. This extraction of problematic elements from the process eliminates complex impurity removal operations while maintaining production efficiency.

Inventive Principle:
Principle #2Taking out (Extraction)

3Ease of manufacture

If hydroxyl-protecting groups are introduced and later deprotected, then the synthesis can proceed, but the operations become more complex and yield decreases

Engineering Contradiction:
Improvesynthesis feasibilityVSAvoidnumber of protection-deprotection steps
Core Design Contradiction:
Ease of manufactureVSDevice complexity

Solution Approach 1:

The patent extracts the hydroxyl-protecting group steps entirely from the synthesis pathway by using a methoxy group that does not require protection or deprotection. This eliminates multiple operational steps, reduces complexity, and prevents yield loss while maintaining synthesis feasibility.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The methoxy group is introduced in advance as a stable substituent that remains intact throughout the synthesis process, eliminating the need for preliminary protection steps and subsequent deprotection steps, thereby simplifying the overall manufacturing process.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS8420821B2Process for production of 4-oxoquinoline compound
Publication Date: 2013.04.16 SHIONOGI & CO LTD
  • US8420821B2 patent drawing
  • US8420821B2 patent drawing
  • US8420821B2 patent drawing

AI summary

The present invention provides a compound useful as a synthetic intermediate for an anti-HIV agent having an integrase inhibitory activity, a production method thereof, and a production method of an anti-HIV agent using the synthetic intermediate. Specifically, the present invention provides, for example, compounds represented by the formulas (6), (7-1), (7-2) and (8):wherein R is a fluorine atom or a methoxy group, R1 is a C1-C4 alkyl group, R2 is a hydroxyl-protecting group, and X2 is a halogen atom, a production method thereof, and a production method of an anti-HIV agent using the synthetic intermediate.